Dengue and dengue hemorrhagic fever

Clinical Microbiology Reviews

Volumn 11, Issue 3, 1998, Pages 480-496

  Gubler, Duane J ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

DEMOGRAPHY; DENGUE; ENDEMIC DISEASE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; MOSQUITO; PATHOGENESIS; PUBLIC HEALTH; REVIEW; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION;

EID: 0031823546     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.3.480     Document Type: Review

References (157)

1. Anonymous. 1986, Dengue hemorrhagic fever, diagnosis, treatment and control. World Health Organization, Geneva, Switzerland.
2. Anonymous. 1997. Dengue in the Americas-time to talk. Lancet 350:455. (Editorial.)
3. Bancroft, W. H., R. M. Scott, K. H. Eckels, C. H. Hoke, T. E. Simms, (Editorial.) K. D. T. Jesrani, P. L. Summers, D. R. Dubois, D. Tsoulos, and P. K. Russell. 1984. Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J. Infect. Dis. 149:1005-1010.
4. Barnes, W. J. S., and L. Rosen. 1974. Fatal hemorrhagic disease and shock associated with primary dengue infection on a pacific island. Am. J. Trop. Med. Hyg. 23:495-506.
5. + cytotoxic T cells (CTLs)-a novel approach to the protection of humans. Virus Genes 9:33-45.
6. Bhamarapravati, N. 1989. Hemostatic defects in dengue hemorrhagic fever. J. Infect. Dis. 2(Suppl. 4):S826-S829.
7. Bhamarapravati, N. 1997. Pathology of dengue infections, p. 115-132. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemmorhagic fever. CAB International, London, United Kingdom.
8. Bhamarapravati, N. 1997. Live attenuated tetravalent dengue vaccine, p. 367-378. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
9. Bhamarapravati, N., P. Tuchinda, and V. Boonyapaknavik. 1967. Pathology of Thailand hemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 61:500-510.
10. Bhamarapravati, N., and S. Yoksan. 1989. Study of bivalent dengue vaccine in volunteers. Lancet i:1077.
11. Bhamarapravati, N., S. Yoksan, T. Chayaniyayothian, S. Angsubhakorn, and A. Bunyaratvej. 1987. Immunization with a live attenuated dengue-2 virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull. W. H. O. 65:185-195.
12. Bielefeldt-Ohmann, H. 1997. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol. 5:409-413.
13. Brandt, W. E. 1988. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. J. Infect. Dis. 157:1105-1111.
14. Brandt, W. E. 1990. Development of dengue and Japanese encephalitis vaccines. J. Infect. Dis. 162:577-583.
15. Brandt, W. E., J. M. McCown, M. K. Gentry, and P. K. Russell. 1982. Infection enhancement of dengue-2 virus in the U937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immun. 36:1036-1041.
16. Bray, M., and C.-J. Lai. 1991. Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc. Natl. Acad. Sci. USA 88:10342-10346.
17. Burke, D. S., A. Nisalak, and M. A. Ussery. 1982. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J. Clin. Microbiol. 15:1034-1042.
18. Burke, D. S., A. Nisalak, D. Johnson, and R. M. Scott. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:172-180.
19. Carey, D. E. 1971. Chikungunya and dengue: a case of mistaken identity? J. Hist. Med. Allied Sci. 26:243-262.
20. Casey, H. L. 1965. Standardized diagnostic complement fixation method and adaptation to micro-test. Public health monograph 74. U.S. Government Printing Office, Washington, D.C.
21. Centers for Disease Control and Prevention. 1995. Imported dengue -United States, 1993 and 1994. Morbid. Mortal. Weekly Rep. 44:353-356.
22. Centers for Disease Control and Prevention. Unpublished data.
23. Chambers, T. J., T. F. Tsai, Y. Pervikov, and T. P. Monath. 1997. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization Meeting. Vaccine 15:1494-1502.
24. Chang, G.-J. 1998. Personal communication.
25. Chen, W., H. Kawano, R, Men, D. Clark, and C.-J. Lai. 1995. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J. Virol. 69:5186-5190.
26. Chungue, E. 1997. Molecular epidemiology of dengue viruses, p. 93-101. In J. F. Saluzzo and B. Dodet (ed.), Factors in the emergence of arbovirus diseases. Elsevier, Paris, France.
27. Chungue, E., R. Marche, R. Plichart, J. P. Boutin, and J. Roux. 1989. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and hemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans. R. Soc. Trop. Med. Hyg. 83:708-771.
28. Clarke, D. H., and J. Casals. 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg. 7:561-577.
29. Deubel, V. 1997. The contribution of molecular techniques to the diagnosis of dengue infection, p. 335-366. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
30. Deubel, V., and V. Pierre. 1994. Molecular techniques for rapid and more sensitive detection and diagnosis of flaviviruses, p. 227-237. In R. C. Spencer, E. P. Wright, and S. W. B. Newsom (ed.), Rapid methods and automation in microbiology and immunology. Intercept, Andover, United Kingdom.
31. Deubel, V., M. Bordier, F. Megret, M. K. Gentry, J. J. Schlesinger, and M. Girard. 1991. Processing, secretion, and immunoreactivity of caboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology 180:442-447.
32. Dietz, V., D. J. Gubler, S. Ortiz, G. Kuno, A. Casta-Velez, G. E. Sather, I. Gomez, and E. Vergne. 1996. The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. P. R. Health Sci. J. 15:201-210.
33. Dulbecco, R. 1956. A study of the basic aspects of neutralization of two animal viruses, Western equine encephalitis virus and poliomyelitis virus. Virology 2:162-205.
34. Ehrankramz, N. J., A. K. Ventura, and R. R. Guadrado. 1971. Pandemic dengue in Caribbean countries and the southern United States: past, present and potential problems. N. Engl. J. Med. 285:1460-1469.
35. Eram, S., Y. Setyabudi, T. I. Sadono, D. S. Sutrisno, D. J. Gubler, and J. Sulianti-Saroso. 1979. Epidemic dengue hemorrhagic fever in rural Indonesia: clinical studies. Am. J. Trop. Med. Hyg. 28:711-716.
36. Gubler, D. J. 1987. Dengue and dengue hemorrhagic fever in the Americas. P. R. Health Sci. J. 6:107-111.
37. Gubler, D. J. 1988. Dengue, p. 223-260. In T. P. Monath (ed.), Epidemiology of arthropod-borne viral diseases. CRC Press, Inc., Boca Raton, Fla.
38. Gubler, D. J. 1989. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Am. J. Trop. Med. Hyg. 40:571-578.
39. Gubler, D. J. 1993. Dengue and dengue hemorrhagic fever in the Americas, p. 9-22. In P. Thoncharoen (ed.). Monograph on dengue/dengue hemorrhagic fever. W.H.O. regional publication SEARO no. 22. World Health Organization, New Delhi, India.
40. Gubler, D. J. 1996. Arboviruses as imported disease agents: the need for increased awareness. Arch. Virol. 11:21-32.
41. Gubler, D. J. 1997. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem, p. 1-22. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
42. Gubler, D. J. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann. Acad. Med. Singapore, in press.
43. Gubler, D. J. Unpublished data.
44. Gubler, D. J., and A. Casta-Velez, 1991. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands. Bull. Pan Am. Health Org. 25:237-247.
45. Gubler, D. J., and G. G. Clark. 1995. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg. Infect. Dis. 1:55-57.
46. Gubler, D. J., and L. Rosen. 1976. A simple technique for demonstrating transmission of dengue viruses by mosquitoes without the use of vertebrate hosts. Am. J. Trop. Med. Hyg. 25:146-150.
47. Gubler, D. J., and G. E. Sather. 1988. Laboratory diagnosis of dengue and dengue hemorrhagic fever, p. 291-322. In A. Homma and J. F. Cunha (ed.), Proceedings of the International Symposium on Yellow Fever and Dengue.
48. Gubler, D. J., and D. W. Trent. 1994. Emergence of epidemic dengue/ dengue hemorrhagic fever as a public health problem in the Americas. Infect. Agents Dis. 2:383-393.
49. Gubler, D. J., D. Reed, L. Rosen, and J. C. J. Hitchcock. 1978. Epidemiologic, clinical and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27:581-589.
50. Gubler, D. J., W. Suharyono, Sumarmo, H. Wulur, E. Jahja, and J. Sulianti Saroso. 1979. Virological surveillance for dengue haemorrhagic fever in Indonesia using the mosquito inoculation technique. Bull W. H. O. 57:931-936.
51. Gubler, D. J., W. Suharyono, R. Tan, M. Abidin, and A. Sie. 1981. Viremia in patients with naturally acquired dengue infection. Bull. W. H. O. 59:623-630.
52. Gubler, D. J., G. Kuno, G. E. Sather, M. Vélez, and A. Oliver. 1984. Use of mosquito cell cultures and specific monoclonal antibodies for routine surveillance of dengue viruses. Am. J. Trop. Med. Hyg. 33:158-165.
53. Gubler, D. J., G. Kuno, G. E. Sather, and S. H. Waterman. 1985. A case of natural concurrent human infection with two dengue viruses. Am. J. Trop. Med. Hyg. 34:170-173.
54. Gubler, D. J., G. E. Sather, G. Kuno, and J. R. Cabrai. 1986. Dengue 3 virus transmission in Africa. Am. J. Trop. Med. Hyg. 35:1280-1284.
55. Guzman, M. G., and G. Kouri. 1996. Advances in dengue diagnosis. Clin. Diagn. Lab. Immunol. 3:621-627.
56. Hall, W. C., T. P. Crowell, D. M. Watts, V. L. R. Barros, H. Kruger, F. Pinheiro, and C. J. Peters. 1991. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin embedded human liver by immunohistochemical analysis. Am. J. Trop. Med. Hyg. 45:408-417.
57. Halstead, S. B. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
58. Halstead, S. B. 1974. Etiologies of the experimental dengues of Suer and Simmons. Am. J. Trop. Med. Hyg. 23:974-982.
59. Halstead, S. B. 1978. Studies on the attenuation of dengue 4. Asian J. Infect. Dis. 2:112-117.
60. Halstead, S. B. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140:527-533.
61. Halstead, S. B. 1980. Dengue hemorrhagic fever - public health problem and a field for research. Bull. W. H. O. 58:1-21.
62. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
63. Halstead, S. B. 1992. The XXth century dengue pandemic: need for surveillance and research. Rapp. Trimest. Stat. Sanit. Mond. 45:292-298.
64. Halstead, S. B., H. Shotwell, and J. Casals. 1973. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J. Infect. Dis. 128:7-14.
65. Halstead, S. B., H. Shotwell, and J. Casals. 1973. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J. Infect. Dis. 128:15-22.
66. Halstead, S. B., and E. J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature (London) 265:739-741.
67. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enchancement by non-neutralizing antibody. J. Exp. Med. 146:210-217.
68. Halstead, S. B., C. N. Venkateshan, M. K. Gentry, and L. K. Larsen. 1984. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 312:1529-1532.
69. Halstead, S. B., A. R. Diwan, J. J. Manchette, N. E. Palumbo, and L. Srisukonth. 1984. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. 1. Attributes of uncloned virus at different passage levels. Am. J. Trop. Med. Hyg. 33:654-665.
70. Hammon, W. M., A. Rudnick, and G. Sather. 1960. New hemorrhagic fevers of children in the Philippines and Thailand. Trans. Assoc. Am. Physicians 73:140-155.
71. Hayes, E. B., and D. J. Gubler. 1992. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 11:311-317.
72. Henchal, E. A., J. M. McCown, M. C. Sequin, M. K. Gentry, and W. E. Brandt. 1983. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am. J. Trop. Med. Hyg. 32:164-169.
73. Hirsch, A. 1883. Dengue, a comparatively new disease: its symptoms, p. 55-81. In Handbook of geographical and historical pathology, vol. 1. Syndenham Society, London, United Kingdom.
74. Hotta, S., and R. Kimura. 1952. Experimental studies on dengue 1. Isolation identification and modification of the virus. J. Infect. Dis. 90:1-9.
75. Howe, G. M. 1977. A world geography of human diseases. Academic Press, Inc., New York, N.Y.
76. Igarashi, A. 1978. Isolation of Singh's Aedes albopictus cell clone sensitive to dengue and chikungunya viruses. J. Gen. Virol. 40:530-544.
77. Innis, B. L. 1995. Dengue and dengue hemorrhagic fever, p. 103-146. In J. S. Porterfield (ed.), Exotic viral infections - 1995. Chapman & Hall, London, United Kingdom.
78. Innis, B. L., A. Nisalak, S. Nimmannitya, S. Kusalerdchariya, V. Chongswasdi, S. Suntayakorn, P. Puttisri, and C. H. Hoke. 1989. An enzymelinked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
79. Kapoor, M., L. Zhang, P. M. Mohan, and R. Padmanabhan. 1995. Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 162:175-180.
80. Kawano, H., V. Rostapshow, L. Rosen, and C.-J. Lai. 1993. Genetic determinants of dengue type 4 virus neurovirulence for mice. J. Virol. 67:6567-6575.
81. Kimura, R., and S. Hotta. 1944. Studies on dengue: antidengue active immunization experiments in mice. Jpn. J. Bacteriol. 1:96-99.
82. Kinney, R. M., S. Butrapet, G. J. Chang, J. T. Roehrig, K. R. Tsuchiya, N. Bhamarapraviti, and D. J. Gubler. 1997. Construction of infectious cDNA clones for dengue 2 16681 virus and its attenuated vaccine derivative, strain PDK-53. Virology 230:300-308.
83. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
84. Kochel, T., S.-J. Wu, K. Raviprakash, P. Hobart, S. L. Hoffman, and C. G. Hayes. 1997. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15:547-552.
85. Kouri, G., M. G. Guzman, L. Valdes, I. Carbonel, D. del Rosario, S. Vazquez, J. Laferte, J. Delgado, and M. V. Cabrera. 1998. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg. Infect. Dis. 4:89-92.
86. Kuberski, T. T., and L. Rosen. 1977. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am. J. Trop. Med. Hyg. 26:533-537.
87. Kuberski, T. T., L. Rosen, D. Reed, and J. Mataika. 1977. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am. J. Trop. Med. Hyg. 26:775-783.
88. Kuno, G., D. J. Gubler, M. Velez, and A. Oliver. 1985. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull. W. H. O. 63:279-286.
89. Kuno, G., I. Gomez, and D. J. Gubler. 1991. An ELISA procedure for the diagnosis of dengue infections. J. Virol. Methods 33:101-113.
90. Kuno, G., D. J. Gubler, and A. Oliver. 1993. Use of original antigenic sin theory to determine the serotypes of previous dengue infections, Trans. R. Soc. Trop. Med. Hyg. 87:103-105.
91. Kuno, G., C. B. Cropp, J. Wong-Lee, and D. J. Gubler. Dengue IgM Immunoblot. Am. J. Trop. Med. Hyg., in press.
92. Kurane, I., and F. A. Ennis. 1997. Immunopathogenesis of dengue virus infections, p. 273-290. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
93. Lai, C.-J., B. Zhao, H. Hori, and M. Bray. 1991. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. USA 88:5139-5143.
94. Laille, M., V. Deubel, and F. Flye Sainte Marie. 1991. Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction. J. Med. Virol. 34:51-54.
95. Lam, S. K., C. B. Chew, G. K. Poon, S. Ramalingam, S. C. Seow, and T. Pang. 1986. Isolation of dengue viruses by intracerebral inoculation of mosquito larvae. J. Virol. Methods 14:133-140.
96. Lam, S. K., M. Y. Fong, E. Chungue, S. Doraisingham, A. Igarashi, M. A. Khin, Z. T. Kyaw, A. Nisalak, C. Roche, D. W. Vaughn, and V. Vorndam. 1996. Multicentre evaluation of dengue IgM dot enzyme immunoassay. Clin. Diagn. Virol. 7:93-98.
97. Lam, S. K., S. Devi, and T. Pang. 1987. Detection of specific IgM in dengue infections. Southeast Asian J. Trop. Med. Public Health 18:532-538.
98. Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G.-J. Chang, and A. V. Vorndam. 1992. Rapid detection and typing of dengue viruses from clinical samples using reverse transcriptase chain reaction. J. Clin. Microbiol. 30: 545-551.
99. Lanciotti, R. S., J. L. Lewis, D. J. Gubler, and D. W. Trent. 1994. Molecular evolution and epidemiology of dengue-3 viruses. J. Gen. Virol. 75:65-75.
100. Lewis, J. A., G. J. Chang, R. S. Lanciotti, R. M. Kinney, L. W. Mayer, and D. W. Trent, 1993. Phylogenetic relationships of dengue-2 viruses. Virology 197:216-224.
101. Mason, P. W., J. M. Dalrymple, M. K. Gentry, J. M. McCown, C. H. Hoke, D. S. Burke, M. J. Fournier, and T. L. Mason. 1989. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:2037-2049.
102. Mason, P. W., S. Pincus, M. J. Fournier, T. L. Mason, R. E. Shope, and E. Paoletti. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294-305.
103. McSherry, J. A. 1982. Some medical aspects of the Darien schema: was it dengue? Scot. Med. J. 27:183-184.
104. 103a.Monath, T. P. Personal communication.
105. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395-2400.
106. Moore, C. G., and C. J. Mitchell. 1997. Aedes albopictus in the United States: ten-year presence and public health implications. Emerg. Infect. Dis. 3:329-334.
107. Morens, D. M., C. N. Venkateshan, and S. B. Halstead. 1987. Dengue 4 virus monoclonal antibodies indentify epitopes that mediate immune enhancement of dengue 2 viruses. J. Gen. Virol. 68:91-98.
108. Newton, E. A. C., and P. Rieter. 1992. A model of the transmission of dengue fever with an evolution of the impact of ultra-low volume (ULV) insecticide application on dengue epidemics. Am J. Trop. Med. Hyg. 47: 709-720.
109. Nobuchi, H. 1979. The symptoms of a dengue-like illness recorded in a Chinese medical encyclopedia. Kanpo Rinsho 26:422-425. (In Japanese.)
110. Pepper, O. H. P. 1941. A note on David Bylon and dengue. Ann. Med. Hist. 3rd Ser. 3:363-368.
111. Pinheiro, F. P. 1989. Dengue in the Americas, 1980-1987. Epidemiol. Bull. 10:1.
112. Pinheiro, F. P., and S. J. Corber. 1997. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q. 50:161-169.
113. Platt, K. B., K. J. Linthicum, K. S. A. Myint, B. L. Innis, K. Lerdthusnee, and D. W. Vaughn. 1997. Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am. J. Trop. Med. Hyg. 57:119-125.
114. Polo, S., G. Ketner, R. Levis, and B. Falgout. 1997. Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. J. Virol. 71:5366-5374.
115. Putnam, J. L., and T. W. Scott. 1995. Blood feeding behavior of dengue-2 virus-infected Aedes aegypti. Am. J. Trop. Med. Hyg. 55:225-227.
116. Reiter, P., and D. J. Gubler. 1997. Surveillance and control of urban dengue vectors, p. 425-462. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
117. Rico-Hesse, R. 1990. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174:479-493.
118. Rico-Hess, R., L. Harrison, R. Salas, D. Tovar, A. Nisalak, C. Ramos, J. R. Boshell, M. de Mesa, R. Nogueira, and A. Travassos da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251.
119. Rigau-Pérez, J. G., and D. J. Gubler. 1997. Surveillance for dengue and dengue hemorrhagic fever, p. 405-423. In D. J. Gubler and G. Kono (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
120. Rigau-Pérez, J. G., D. J. Gubler, A. V. Vorndam, and G. G. Clark. 1994. Dengue surveillance-United States, 1986-1992. Morbid. Mortal. Weekly Rep. 43(SS-2):7-19.
121. Rodier, G., D. J. Gubler, S. E. Cope, R. Bercion, C. B. Cropp, A. K. Soliman, J. Bouloumie, J.-J. Piccolo, D. Polycarpe, J. A. Abdourhaman, P. Delmaire, J.-P. Bonnet, J.-P. Parra, G. G. Gray, and D. J. Fryauff. 1995. Epidemic dengue 2 in the city of Djibouti, Horn of Africa, 1991-1992. Trans. R. Soc. Trop. Med. Hyg. 90:237-240.
122. Roehrig, J. T., A. H. Johnson, A. R. Hunt, B. J. Beaty, and J. H. Mathews. 1992. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J. Virol. 66:3385-3390.
123. Roehrig, J. T., J. H. Mathews, P. A. Risi, J. R. Brubaker, and A. R. Hunt. 1992. Mapping of biologically active helper T-cell epitopes on the flavivirus envelope glycoprotein, p. 277-281. In F. Brown, R. M. Chanock, H. Ginsberg, and R. A. Lerner (ed.), Vaccines 92. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
124. Rosen, L. 1977. The Emperor's new clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 26:337-343.
125. Rosen, L. 1982. Dengue - an overview, p. 484-493. In J. S. Mackenzie (ed.), Viral diseases in Southeast Asia and the Western Pacific. Academic Press, Ltd., Sydney, Australia.
126. Rosen, L., and D. J. Gubler. 1974. The use of mosquitoes to detect and propagate dengue viruses. Am. J. Trop. Med. Hyg. 21:1153-1160.
127. Rosen, L., and D. J. Gubler. Unpublished data.
128. Rothman, A. L. 1997. Viral pathogenesis of dengue infections, p. 245-272. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
129. Rush, A. B. 1789. An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. Medical enquiries and observations, p. 104-117. Prichard and Hall, Philadelphia, Pa.
130. Russell, P. K., and A. A. Nisalak. 1967. Plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99:285-290.
131. Russell, P. K. 1978. Progress toward dengue vaccines. Asian J. Infect. Dis. 2:118-120.
132. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30-50.
133. Sabin, A. B., and R. W. Schlesinger. 1945. Production of immunity to dengue with virus modified by propagation in mice. Science 101:640-642.
134. Sangkawibha, N., S. Rojanasuphot, S. Ahandrink, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. Am. J. Epidemiol. 120:653-669.
135. Scherer, W. E., P. K. Russell, L. Rosen, J. Casals, and R. W. Dickerman. 1978. Experimental infection of chimpanzees with dengue viruses. Am. J. Trop. Med. Hyg. 27:590-599.
136. Scott, T. W., A. Naksathit, J. F. Day, P. Kittayapong, and J. D. Edman. 1997. A fitness advantage for Aedes aegypti and the viruses it transmits when females feed only on human blood. Am. J. Trop. Med. Hyg. 57:235-239.
137. Siler, J. F., M. W. Hall, and A. Hitchens. 1926. Dengue, its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity and prevention. Philipp. J. Sci. 29:1-304.
138. Soper, F. L., D. B. Wilson, S. Lima, and W. S. Antunes. 1943. The organization of permanent nationwide anti-Aedes aegypti measures in Brazil. The Rockefeller Foundation, New York, N.Y.
139. Sumarmo, S. P. S. 1983. Demam berdarah dengue pada anak di Jakarta. Ph.D. thesis. University of Indonesia, Jakarta.
140. Sumarmo, S. P. S., H. Wulur, E. Jahja, and D. J. Gubler. 1983. Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull. W. H. O. 61:693-701.
141. Tan, B.-H., J. Fu, R. J. Sugrue, E.-H. Yap, Y.-C. Chan, and Y. H. Tan. 1996. Recombinant dengue type 1 virus NSS protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216:317-325.
142. Tesh, R. B. 1979. A method for the isolation and identification of dengue viruses, using mosquito cell cultures. Am. J. Trop. Med. Hyg. 28:1053-1059.
143. Thet-Win. 1982. Detection of dengue virus by immunofluorescence after intracerebral inoculation of mosquitoes. Lancet i:53-54.
144. Trent, D. W., J. A. Grant, T. P. Monath, C. L. Manske, M. Corina, and G. E. Fox. 1989. Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology 172:523-535.
145. Trent, D. W., R. M. Kinney, and C. Y.-H. Huang. 1997. Recombinant dengue virus vaccines, p. 379-404. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
146. Vaughn, D. W., C. H. Hoke, S. Yoksan, R. LaChance, B. L. Innis, R. Rice, and N. Bhamarapravati. 1996. Testing of dengue-2 live attenuated vaccine (strain 16681) (PDK-53) in ten American volunteers. Vaccine 14:329-336.
147. Vaughn, D. W., A. Nisalak, S. Kalayanarooj, T. Solomon, N. M. Dung, A, Cuzzuhbo, and P. L. Devine. 1998. Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J. Clin. Microbiol. 36: 234-238.
148. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, A. L. Rothman, F. A. Ennis, and A. Nisalak. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176: 322-330.
149. Vorndam, V., and G. Kuno. 1997. Laboratory diagnosis of dengue virus infections, p. 313-334. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever - 1997. CAB International, London, United Kingdom.
150. Waterman, S. H., and D. J. Gubler. 1989. Dengue fever. Clin. Dermatol. 7:117-122.
151. Westaway, E. G., and J. Blok. 1997. Taxonomy and evolutionary relationships of flaviviruses, p. 147-173. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom.
152. Wisseman, C. L., Jr., B. H. Sweet, E. C. Rosenzweig, and O. R. Rylar. 1963. Attenuated living type 1 dengue vaccines. Am. J. Trop. Med. Hyg. 12:620-623.
153. Wittesjo, B., R. Eitrem, and B. Niklasson. 1993. Dengue fever among Swedish tourists. Scand. J. Infect. Dis. 25:699-704.
154. Wu, S.-J., B. Hanson, H. Paxton, A. Nisalak, D. W. Vaughn, C. Rossi, E. A. Henchal, K. R. Porter, D. M. Watts, and C. G. Hayes. 1997. Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus. Clin. Diagn. Lab. Immunol. 4:452-457.
155. Yoksan, S., N. Bhamarapravati, and S. B. Halstead. 1986. Dengue virus vaccine development: study on biological markers of uncloned dengue 1-4 viruses serially passaged in primary kidney cells, p. 35-38. In T. D. St. George, B. H. Kay, and J. Blok (eds.), Arborvirus research in Australia. Proceedings of the Fourth Symposium. CSIRO and Queensland Institute of Medical Research, Brisbane, Australia.
156. 2 cells. Am. J. Trop. Med. Hyg, 17:441-448.
157. Zaki, S. R., and C. J. Peters. 1997. Viral hemorrhagic fevers, p. 347-364. In D. H. Connor, F. W. Chandler, D. A. Schwartz, H. J. Manz, and E. E. Lack (ed.), Diagnostic pathology of infectious diseases. Appleton & Lange, Stamford, Conn.